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Stroke is a rare but serious adverse event associated with percutaneous coronary interven-
tion (PCI). However, the relative risk of stroke between stable patients undergoing a direct
PCI strategy and those undergoing an initial optimal medical therapy (OMT) strategy has
not been established yet. This study sought to investigate if, in patients with stable coronary
artery disease (SCAD), an initial strategy PCI is associated with a higher risk of stroke than
a strategy based on OMT alone.
Methods
We performed a meta-analysis of 6 contemporary randomized control trials in which 5673
patients with SCAD were randomized to initial PCI or OMT. Only trials with stent utilization
more than 50% were included. Study endpoint was the rate of stroke during follow up.
Results
Mean age of patients ranged from 60 to 65 years and stent utilization ranged from 72% to
100%. Rate of stroke was 2.0% at a weighted mean follow up of 55.3 months. On pooled
analysis, the risk of stroke was similar between patients undergoing a PCI plus OMT and
those receiving only OMT (2.2% vs. 1.8%, OR on fixed effect = 1.24 95%CI: 0.85–1.79).
There was no heterogeneity among the studies (I2 = 0.0%, P = 0.15). On sensitivity
analysis after removing each individual study the pooled effect estimate remains
unchanged.
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Conclusions
In patients with SCAD an initial strategy based on a direct PCI is not associated with an
increased risk of stroke during long-term follow up compared to an initial strategy based on
OMT alone.
Introduction
In patients with stable coronary artery disease (SCAD) the role of percutaneous coronary inter-
vention (PCI) is controversial. Indeed, data from recent randomized clinical trials (RCT) [1–3]
and meta-analyses[4–6] have consistently shown that in patients with SCAD, PCI does not
reduce the risk of death and myocardial infarction (MI) compared with optimal medical treat-
ment (OMT). Furthermore the attempts to identify patients at higher risk, such as those with
documented myocardial ischemia[7] or diabetes[2] that would benefit from an interventional
strategy have failed. On the other hand, in most of the randomized comparisons, the patients
with SCAD treated with PCI had a better and faster symptoms relief than those treated medi-
cally. Yet, a substantial proportion of patients belonging to the latter group crossed over and
underwent PCI. Thus, the choice of referring patients to an initial conservative strategy based
on either the optimization of medical treatment or a direct PCI strategy plus OMT should take
into account several factors such as the presence and the intensity of symptoms, the patient’s
risk profile (for example patients with marked signs of myocardial ischemia, systolic left ventri-
cle dysfunction, high risk coronary obstructions, comorbidities that have been scarcely repre-
sented in randomized clinical trials) and intervention hazards. Regarding this latter aspect,
stroke following PCI represents undoubtedly a dismal complication with severe disability and
high mortality[8,9]. Data from large registries [8,9] suggest that guiding catheter manipulation,
use of anticoagulant and potent antiplatelet inhibitors (such as glycoprotein IIb/IIIa), especially
in technically difficult PCI [9], may increase the risk of ischemic and hemorrhagic stroke,
respectively. However, the relative risk of stroke between stable patients undergoing a direct
PCI strategy and those undergoing an initially conservative strategy has not been established
yet. Indeed, all RCTs comparing PCI with OMT in stable patients were far underpowered to
detect a difference in terms of such a rare event as stroke. Therefore, we performed a systematic
review and meta-analysis of contemporary RCTs to investigate if PCI plus OMT is associated
with a higher risk of stroke than OMT alone in patients with SCAD.
Methods
Study selection and study endpoint
We carried out a systematic review of the available publications according to the current
PRISMA guidelines to perform meta-analyses of RCT[10] (S1 Table). We searched for relevant
articles, filtered by RCT, published in the MEDLINE and the Cochrane Library using the fol-
lowing key words that were variously combined (S1 Text): “stable angina”, “stable coronary
artery disease”, “medical therapy”, “PCI”, “stent”. No language restriction was used. We also
checked the reference lists of reviews and relevant articles.
Inclusion criteria were as follows. 1. RCT design, 2. Comparison between PCI plus OMT
and OMT alone, 3. Stent implantation in more than 50% of PCI patients 4. Data on stroke
available.
For studies that compared OMT with separate arms of PCI and coronary bypass only data
on comparison between OMT and PCI were extracted.
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We excluded trials that included patients with a recent (within 6 months) episode of acute
coronary syndrome. Trials that compared OMT with revascularization as a whole (either PCI
or coronary bypass) were also excluded. Two investigators (N.T, G.G.) independently reviewed
the titles, abstracts, and studies to determine whether they met the inclusion criteria. Conflicts
between reviewers were resolved by consensus.
The study endpoint was the rate of stroke based on the definition applied in each study. For the
endpoint we used data from the longest follow up available to a maximum of 5-year follow up.
Data were extracted on the basis of the intention-to-treat populations.
Statistical Analysis
Odd Ratios (OR) and 95% Confidence Intervals (95% CI) were used as the summary statistic. The
pooled OR was calculated by using both fixed-effect (inverse variance weighted) and random-effect
(DerSimonian and Laird) models. Between-study heterogeneity of effects was analyzed using the
χ2 and inconsistency across study results quantified by I2 statistics, with I2<25%, 25% I250%,
and I2> 50%, respectively, representing mild, moderate, and severe inconsistency.
Sensitivity analysis was performed by evaluating the influence of removing individual stud-
ies on the pooled OR. The possibility of publication bias was assessed both visually by funnel
plot and Harbord’s test. Statistical analyses were performed using Stata/SE 11.2 (StataCorp LP,
College Station, TX).
Results
Fig 1 shows the flow chart for the study analysis (Poster presentation at TCT 2015; http://
content.onlinejacc.org/article.aspx?articleid=2452937). Of 133 potentially relevant articles ini-
tially screened, 6 met the inclusion criteria and were included in the meta-analysis with a total of
5673 patients[1–3,11–13] (S2 Text). Table 1 shows the main characteristics of the studies
included. Stent utilization ranged from 72% to 100%. Definition of optimal medical therapy was
provided in all studies but one. Most of the studies had 5-year follow up available[1,2,13,14], 2
studies reported data on a shorter follow up (1-year[12] and 2-year[3], respectively).
Mean age of patients ranged from 60 to 65 years with a weighted mean age of 62.3 years. All
studies enrolled predominantly male patients (Table 2). Utilization of aspirin was equal or greater
than 80% in all studies. Beta-blockers and statins were used in more than 60% of patients with
the exception of 1 trial[13] in which they were used in nearly 50%. Angiotensin converting
enzyme inhibitors or angiotensin receptor blockade were used in more than 60% in most studies.
Among the 5668 patients included in the main analysis [in the Japanese stable angina pecto-
ris study (JSAP) [13] outcomes were not reported for 5 patients) the rate of stroke was 2.0% at
a weighted mean follow up of 55.3 months. On pooled analysis, the risk of stroke was similar
between patients undergoing PCI plus OMT and those receiving only OMT (2.2% vs. 1.8%, OR
on fixed effect = 1.24 95%CI: 0.85–1.79). There was no heterogeneity among the studies (I2 =
0.0%, P = 0.915) [Fig 2].
Fig 3 shows that after removing each individual study the pooled effect estimate remains
unchanged.
The funnel plot was very symmetric showing the lack of publication bias (Fig 4). The Har-
bord test further supports this result (p value for small-study effect = 0.765).
Discussion
The main result of the present study, drawn from 6 RCTs including 5673 patients with SCAD
followed up for a mean time of 55 months, is that in patients with SCAD an initial strategy of
PCI plus OMT is not associated with an increased risk of stroke compared to OMT alone.
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Although PCI is widely used for the management of patients with SCAD its role is contro-
versial[15]. Indeed recent clinical trials(1–3) and meta-analyses [4–7] have shown that in
patients with stable angina an initial PCI strategy plus medical therapy does not reduce the risk
of death or MI compared to OMT alone. On the other hand from the same sources stem the
evidences that PCI is associated with a better and more rapid symptoms relief. Accordingly
whether a patients with stable angina should be referred to invasive management or not still
represents a major question that physicians have to face in daily clinical practice. In particular
among factors that may influence this choice the evaluation of intervention hazards should be
taken into account. Stroke is a rare but devastating complication related to PCI[8,9]. Although
its incidence, risk factors and outcome have been widely described[8,9,16–18] a direct compari-
son in patients with SCAD aimed to investigate if initial PCI plus OMT strategy is associated
with a higher risk of stroke than OMT alone has not been performed so far.
The results of our meta-analysis, showing that the risk of stroke is not different between
patients managed with PCI and those managed with OMT, are therefore noteworthy.
Fig 1. Study flow chart. Abbreviations: CABG = coronary artery bypass grafting; PCI = percutaneous coronary intervention.
doi:10.1371/journal.pone.0158769.g001
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The strength of this findings rely on the satisfaction of all requirements for meta-analysis in
term of low heterogeneity, no publication bias and sensitivity analyses.
There may be different reasons to explain our findings. First, the risk of stroke in patients
undergoing PCI has been historically associated with procedural factors with an incidence during
hospitalization less than 0.4%[16,17]. Guide catheter manipulation, use of anticoagulant and
potent antiplatelet inhibitors may increase the risk of ischemic and hemorrhagic stroke, respec-
tively. In a recent study(18) from the British Cardiovascular Intervention Society, including
426046 patients undergoing PCI, the incidence of 30-day ischemic and haemorrhagic stroke was
0.10% and 0.03%. Patients with SCAD were at lower risk compared to patients with ACS.
This quite low risk could also be paid by a considerable portion of patients treated with
OMT alone due to the high rate of cross over during long-term follow up, realizing a sort of
catch up in the risk of stroke. Indeed, the need of elective PCI in the OMT arm ranged from 9%
of The Medicine, Angioplasty, or Surgery Study II study to 36.5% of the JSAP study [in the
COURAGE study and Fracional Flow Reserve versus Angiography for Multivessel Evaluation
2 (FAME II) trial the rate of elective PCI for persistent angina was 32.6% and 26.5%,
respectively).
Second, the risk related to PCI could be partly outfitted during follow up by the fact that
patients undergoing to PCI are more likely to receive dual antiplatelet therapy compared to
patients managed medically due to stent implantation routinely used in contemporary clinical
practice. In fact, it is known that dual antiplatelet therapy reduce the risk of stroke as a whole
compared to aspirin alone[19,20]. Notably in the present meta-analysis in order to reflect a
contemporary clinical practise we included only study with a rate of stent implantation more
than 50%.
Table 2. Characteristics of patients.
MASS II11 Hambrecht
et al12















Patients (n) 205 203 50 51 1149 1138 188 191 798 807 447 441
Age, mean (yr) 60 60 60 62 62 62 65 64 62 62 64 64
Male (%) 67 69 100 100 85 85 75 75 68 70 80 77
Prior MI (%) 52 39 39 52 38 39 14 15 30 32 37 38
Diabetes (%) 23 36 22 23 32 35 40 40 100 100 28 27
Multivessel
disease (%)
100 100 40 54 69 70 33 33 20 30 44 41
Medical therapy
(%)
Aspirin 80 80 98 98 96 95 92 91 94 94 87 90
Beta blocker 61 68 86 88 85 89 44 52 84 88 76 78
ACE-I or ARB 30 29 88 74 62 65 42 39 91 92 69 70
Statin 73 68 80 72 86 89 49 45 95 95 83 82
ACE-I = angiotensin converting enzyme inhibitors; ARB = angiotensin receptor blockers; BARI 2 = Bypass
Angioplasty Revascularization Investigation 2 Diabetes; COURAGE = Clinical Outcome Utilizing
Revascularization and Aggressive Drug Evaluation; FAME 2 = Fracional Flow Reserve versus Angiography
for Multivessel Evaluation 2; JSAP = Japanese stable angina pectoris study; MASS II = The Medicine,
Angioplasty, or Surgery Study II, MI = myocardial infarction, OMT = optimal medical therapy;
PCI = percutaneous coronary intervention.
doi:10.1371/journal.pone.0158769.t002
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Study limitations
The results of the present study should be interpreted in light of some limitations.
This meta-analysis was based on aggregate data of randomized clinical trials that tradition-
ally are conducted in highly-experienced centres and enrol patients with low risk clinical pro-
file. Therefore, generalization of effect estimates should be undertaken with caution. Indeed,
traditional risk factors for stroke in patients undergoing PCI such as advance age, prior stroke,
atrial fibrillation and procedural complexity may be less represented in clinical trials compared
to a real world setting. Given these observations whether PCI is associated or not with an
increased risk of stroke as compared to OMT also in higher risk patients should be evaluated
by further investigations.
Although in the present study we included only trials with> 50% of stent utilization to
reflect a modern PCI practise it should be taken into account that these trials were conducted
in different era in terms of type of stent, type and duration of dual antiplatelet therapy (this lat-
ter aspect related to the rate of drug eluting stent utilization).
Fig 2. Risk of stroke in patients with PCI based strategy vs. patients with OMT based strategy. Abbreviations: CI = confidence intervals.
doi:10.1371/journal.pone.0158769.g002
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In the present study we included more than 5000 patients; it is not excludible that a study
with a larger sample size could be able to detect a significant higher risk of stroke in patients
undergoing a PCI based approach compared to OMT alone. To date, however, there are no
larger studies available. Nevertheless, assuming a stroke rate of 1.9% in the PCI group and 1.2%
in the OMT group; i.e. 37 relative risk reduction [based on data from the Clinical Outcome Uti-
lizing Revascularization and Aggressive Drug Evaluation (COURAGE) study] 5170 patients
would be required for a study power of 80% with a type I error of 0.05. Finally, it would be of
interest to evaluate also the early risk of stroke related to coronary interventions however data
on peri-procedural stroke and timing of stroke were missing in most of the studies included in
the present meta-analysis. Nonetheless data from recent meta-analyses [21] of 19 trials includ-
ing 10944 patients randomized to coronary bypass versus PCI showed that the 30-day rate of
stroke in the PCI arm was quite low (1.2% and 0.34, respectively). Yet, these findings have been
confirmed also in a recent European survey showing in stable patients a rate of in hospital
stroke following PCI of 0.3% [9]. Therefore, assuming a stroke rate of 0.3% in the PCI arm to
detect a significant relative risk reduction of 37% in the OMT arm, with a study power of 80%
and an alfa level of 0.05, 9920 patients should be recruited.
Conclusions
In this meta-analysis of available contemporary RCTs including patients with SCAD an initial
strategy based on a direct PCI is not associated with an increased risk of stroke during long-
term follow up compared to an initial strategy based on OMT alone.
Fig 3. Risk of stroke in patients with PCI based strategy vs. patients with OMT based strategy.OR estimates given named study is omitted.
Abbreviations: CI = confidence intervals OR = odds ratio.
doi:10.1371/journal.pone.0158769.g003
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Fig 4. Estimation of publication bias. A funnel plot of SE versus ln(OR) for the meta-analysis. When the standard error is used on the y axis of a funnel plot,
it is conventional to reverse the axis so that the most precise studies are displayed at the top of the plot. They tend to cluster near the mean effect size.
Smaller studies are depicted at the bottom of the graph and tend to be dispersed in a range of value. In absence of publication bias as shown in the present
figure the studies are distributed symmetrically about the combined effect size. The pseudo 95% confidence limits illustrate the expected 95% confidence
interval about the pooled fixed-effects estimate for the meta-analysis.
doi:10.1371/journal.pone.0158769.g004
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